Business · 23/03/2011
FDA Classifies Ovarian Adnexal Mass Assessment Score Test System as Class II Device with Special Controls
The FDA has classified the Ovarian Adnexal Mass Assessment Score Test System as a Class II device, requiring special controls to ensure safety and effectiveness, and has made the relevant guidance document available
Original source language: Federal Register — Health and Human ServicesOpen original release →